The investigation for the period of proton pump inhibitor for gastric ulcer after endoscopic submucosal dissection

The investigation for the period of proton pump inhibitor for gastric ulcer after endoscopic submucosal dissection - The investigation for the period of PPI for gastric ulcer after ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006951

Enrollment

Registered

2011-12-26

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with gastric cancer or adenoma who underwent ESD

Interventions

esomeprazole 20mg per day for 4 weeks esomeprazole 20mg per day for 2 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with gastric cancer or adenoma who underwent ESD

Exclusion criteria

Exclusion criteria: (1) patients with gastrectomy during treatment (2) patients who are pregnant or nursing (3) patients with severe liver or renal dysfunction (4) patients with use of anti-thrombosis drug (5) patients wit bleeding tendency (6) drug allergy for esomeprazole (7) patients who are diagnosed as unsuitable for this trial by investigator

Design outcomes

Primary

Measure	Time frame
Reduction rate in area of gastric ulcer after ESD	—

Secondary

Measure	Time frame
QOL (GSRS) at 4 weeks after ESD Relation between GSRS and reduction rate.	—

Countries

Japan

Contacts

Public ContactMakoto Arai

Chiba University Hospital Gastroenterology

araim-cib@umin.ac.jp043-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026